Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ TCR V delta 1 Monoclonal Antibody (TS8.2)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ TCR1730

Catalog No. PITCR1730


Only null left
Edge
Add to Cart

Description

Description

TCR1730 targets TCR V delta 1 in FACS, IHC (F), and TCA applications and shows reactivity with Human samples. The TCR1730 immunogen is human TCR V delta 1.

The T Cell Receptor gamma-delta (TCR gamma delta) is a heterodimeric membrane receptor that consists of the highly variable gamma and delta chains expressed as part of a complex with the invariant CD3 proteins. Gamma-delta T cells are less frequent than alpha-beta T cells but compose a substantial part of T cells found at epithelial borders including the gut mucosa resident intraepithelial lymphocytes (IEL). The antigenic stimuli required for gamma-delta T cell receptor activation are not well understood and are thought to be mainly MHC class-independent.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

TCR V delta 1
Monoclonal
0.15 mg/mL
PBS with 0.5% BSA and 0.1% sodium azide
0
Mouse
Protein G
RUO
6964
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Responsibly packaged
Flow Cytometry, Immunohistochemistry (Frozen), T-Cell Activation
TS8.2
Unconjugated
TRD
TRD
Human TCR V delta 1.
200 μg
Primary
Human
Antibody
IgG1
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.